Researcher
Philippe Nafteux
- Disciplines:Respiratory medicine
Affiliations
- Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE) (Division)
Member
From1 Jan 2020 → Today - Thoracic Surgery (Division)
Member
From25 Feb 2008 → 31 Dec 2019
Projects
1 - 10 of 12
- Neoadjuvant therapy in the treatment of esophageal adenocarcinoma: one size doesn’t fit allFrom14 Nov 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Multicenter validation trial of [18F]AlF-FAPI-74 for PET imaging of cancer-associated fibroblasts through fibroblast activation protein inhibitors (FAPI) in digestive tumorsFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Prevention of infectious complications after esophageal resectionFrom20 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Breath Analysis In Esophageal Cancer: The evolution towards minimally invasive patient-tailored diagnosticsFrom25 Jan 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Personalized multimodal treatment for resectable esophageal cancer by detecting minimal residual disease (MRD) using circulating tumor DNA (ctDNA):From11 Jan 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Implementation, optimisation and evaluation of proton therapy in esophageal cancerFrom1 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- EFFECTS trial: assessing the influence of timing of Enteral Feeding support in Esophageal Cancer patients on muscle functTION and SurvivalFrom1 Oct 2018 → 30 Sep 2022Funding: FWO Applied Biomedical Research (TBM)
- " Is lymph node response an important prognosticator in esophageal adenocarcinoma patients after neoadjuvant chemoradiation followed by surgery? "From31 May 2018 → 30 Dec 2019Funding: Own budget, for example: patrimony, inscription fees, gifts
- Exploring strategies to reduce toxicity in the multimodal treatment of esophageal cancerFrom1 Jun 2017 → 31 May 2021Funding: Nonprofit institution or equivalents
- Detection of circulating tumor cells in potentially resectable adenocarcinoma of the distal esophagus and the gastro-esophageal junction does not increase in portal venous blood samples compared to peripheral venous blood samples.From1 Jan 2017 → 31 Dec 2019Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
31 - 40 of 204
- Risk Prediction Model of 90-Day Mortality After Esophagectomy for Cancer(2021)
Authors: Philippe Nafteux
Pages: 836 - 845 - Is Re-introducing Major Open and Minimally Invasive Surgery during COVID-19 Safe for Patients and Healthcare Workers? An International, Multi-centre Cohort Study in the Field of Oesophago-gastric Surgery(2021)
Authors: Johnny Moons, Philippe Nafteux
Pages: 4816 - 4826 - Exploring the concept of centralization of surgery for benign esophageal diseases: a Delphi based consensus from the European Society for Diseases of the Esophagus (Feb, doab013, 2021)(2021)
Authors: Marialuisa Lugaresi, Philippe Nafteux, Magnus Nilsson, John V Reynolds, Riccardo Rosati, Sebastian F Schoppmann, Eduardo M Targarona, Sandro Mattioli
- Intranodal Lymphangiography With High-Dose Ethiodized Oil Shows Efficient Results in Patients With Refractory, High-Output Postsurgical Chylothorax: A Retrospective Study(2021)
Authors: Hans Van Veer, Philippe Nafteux, Lieven Depypere, Willy Coosemans, Geert Maleux
Pages: 1 - 6 - Perioperative fluid management in esophagectomy for cancer and its relation to postoperative respiratory complications(2021)
Authors: Johnny Moons, Philippe Nafteux, Hans Van Veer, Lieven Depypere, Willy Coosemans, Toni Lerut, Arne Neyrinck
- Fit-for-Discharge Criteria after Esophagectomy: An International Expert Delphi Consensus(2021)
Authors: Philippe Nafteux, Hans Van Veer
- Evaluation of a marker independent isolation method for circulating tumor cells in esophageal adenocarcinoma(2021)
Authors: Lieven Depypere, Philippe Nafteux
Pages: 1 - 11 - Proposal for the delineation of neoadjuvant target volumes in oesophageal cancer(2021)
Authors: Gilles Defraene, Philippe Nafteux, Karin Haustermans
Pages: 102 - 112 - Corrigendum to "Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis".(2021)
Authors: Patrick Schöffski, Daphne Hompes, Veerle Boecxstaens, Paul De Leyn, Willy Coosemans, Dirk Van Raemdonck, Esther Hauben, Raf Sciot, Paul Clement, Oliver Bechter, et al.
Pages: 4653987 - Gastro esophageal reflux disease and surgical treatment(2021)
Authors: Toni Lerut, Hans Van Veer, Philippe Nafteux, Willy Coosemans, Lieven Depypere
Pages: 253 - 280Number of pages: 27